Related Experiment Video
Updated: Aug 29, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Radiotherapy for muscle-invasive urinary bladder cancer in elderly patients
Alexander Agranovich1, Piotr Czaykowski, David Hui
1BC Cancer Agency, Fraser Valley Cancer Centre, Surrey, British Columbia, Canada.
Objective:
To review retrospectively the outcome and toxicity of Radiotherapy (RT) in the cohort of elderly patients (EP) with muscle-invasive urinary bladder carcinoma (MIUBC).
Methods:
Thirty-six EP were treated with RT with radical intent. The age of the cohort ranged from 71 to 89 years with a median of 79 years. Eighty percent of the patients had Easter Cooperative Oncology Group (ECOG) 0 and 1 performance status. Conventional and accelerated fractionation RT regimen were utilized.
Results:
With median follow up of 45.8 months, the median survival was 23.9 months. There was a trend toward better survival in patients treated with the accelerated fractionation regimen. The median survival for that group (12) has not yet been reached, where it is 9.7 months for the group (24) treated with conventional fractionation. Treatment related toxicity was low for any RT regimens.
Conclusion:
RT is well tolerated by EP with good baseline performance status. The role of accelerated fractionation should be tested by conducting randomized trials.
